FdaApplication
ANDA 217217
Identifiers
- fda_app_no: ANDA217217
Properties
| Property | Value |
|---|---|
| applicant_name | BIOCON PHARMA LTD |
| application_type | ANDA |
| approval_date | 2025-03-03 |
Products (6)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DASATINIB | DASATINIB | 50MG | TABLET;ORAL |
| DASATINIB | DASATINIB | 20MG | TABLET;ORAL |
| DASATINIB | DASATINIB | 70MG | TABLET;ORAL |
| DASATINIB | DASATINIB | 140MG | TABLET;ORAL |
| DASATINIB | DASATINIB | 80MG | TABLET;ORAL |
| DASATINIB | DASATINIB | 100MG | TABLET;ORAL |
6 products